Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 383

1.

Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen.

McKenney D, Pouliot KL, Wang Y, Murthy V, Ulrich M, Döring G, Lee JC, Goldmann DA, Pier GB.

Science. 1999 May 28;284(5419):1523-7.

2.

Vaccine potential of poly-1-6 beta-D-N-succinylglucosamine, an immunoprotective surface polysaccharide of Staphylococcus aureus and Staphylococcus epidermidis.

Mckenney D, Pouliot K, Wang Y, Murthy V, Ulrich M, Döring G, Lee JC, Goldmann DA, Pier GB.

J Biotechnol. 2000 Sep 29;83(1-2):37-44. Review.

PMID:
11000458
3.

Purified capsular polysaccharide-induced immunity to Staphylococcus aureus infection.

Lee JC, Perez NE, Hopkins CA, Pier GB.

J Infect Dis. 1988 Apr;157(4):723-30.

PMID:
3346565
4.
5.

A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis model.

Kuklin NA, Clark DJ, Secore S, Cook J, Cope LD, McNeely T, Noble L, Brown MJ, Zorman JK, Wang XM, Pancari G, Fan H, Isett K, Burgess B, Bryan J, Brownlow M, George H, Meinz M, Liddell ME, Kelly R, Schultz L, Montgomery D, Onishi J, Losada M, Martin M, Ebert T, Tan CY, Schofield TL, Nagy E, Meineke A, Joyce JG, Kurtz MB, Caulfield MJ, Jansen KU, McClements W, Anderson AS.

Infect Immun. 2006 Apr;74(4):2215-23.

6.
7.

Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated Staphylococcal Poly-N-acetyl-beta-(1-6)-glucosamine.

Maira-Litrán T, Kropec A, Goldmann DA, Pier GB.

Infect Immun. 2005 Oct;73(10):6752-62. Erratum in: Infect Immun. 2005 Nov;73(11):7789.

8.

Immune responses to a Staphylococcus aureus GapC/B chimera and its potential use as a component of a vaccine for S. aureus mastitis.

Perez-Casal J, Prysliak T, Kerro-Dego O, Potter AA.

Vet Immunol Immunopathol. 2006 Jan 15;109(1-2):85-97. Epub 2005 Sep 13.

PMID:
16165220
10.

Staphylococcus aureus capsule type 8 antibodies provide inconsistent efficacy in murine models of staphylococcal infection.

Cook J, Hepler R, Pancari G, Kuklin N, Fan H, Wang XM, Cope L, Tan C, Joyce J, Onishi J, Montgomery D, Anderson A, McNeely T.

Hum Vaccin. 2009 Apr;5(4):254-63. Epub 2009 Apr 10.

PMID:
18787395
11.

Staphylococcus aureus vaccine against mastitis in dairy cows, composition and evaluation of its immunogenicity in a mouse model.

Leitner G, Lubashevsky E, Trainin Z.

Vet Immunol Immunopathol. 2003 Jun 20;93(3-4):159-67.

PMID:
12814701
12.
13.

Vaccination as infection control: a pilot study to determine the impact of Staphylococcus aureus vaccination on nasal carriage.

Creech CB 2nd, Johnson BG, Alsentzer AR, Hohenboken M, Edwards KM, Talbot TR 3rd.

Vaccine. 2009 Dec 10;28(1):256-60. doi: 10.1016/j.vaccine.2009.09.088. Epub 2009 Sep 30.

PMID:
19799842
14.

Safety and immunogenicity of a booster dose of Staphylococcus aureus types 5 and 8 capsular polysaccharide conjugate vaccine (StaphVAX) in hemodialysis patients.

Fattom A, Fuller S, Propst M, Winston S, Muenz L, He D, Naso R, Horwith G.

Vaccine. 2004 Dec 16;23(5):656-63.

PMID:
15542186
15.

Prospects for active and passive immunization against Staphylococcus aureus.

Shinefield HR, Black S.

Pediatr Infect Dis J. 2006 Feb;25(2):167-8. Review. No abstract available.

PMID:
16462297
16.

Heterogeneous in vivo expression of clumping factor A and capsular polysaccharide by Staphylococcus aureus: implications for vaccine design.

Nanra JS, Timofeyeva Y, Buitrago SM, Sellman BR, Dilts DA, Fink P, Nunez L, Hagen M, Matsuka YV, Mininni T, Zhu D, Pavliak V, Green BA, Jansen KU, Anderson AS.

Vaccine. 2009 May 26;27(25-26):3276-80. doi: 10.1016/j.vaccine.2009.01.062. Epub 2009 Feb 5.

PMID:
19200819
17.

Potential for vaccination against infections caused by Staphylococcus aureus.

Foster TJ.

Vaccine. 1991 Apr;9(4):221-7. Review.

PMID:
2058264
18.

Prevention of Staphylococcus aureus infections: advances in vaccine development.

Shinefield HR, Black S.

Expert Rev Vaccines. 2005 Oct;4(5):669-76. Review.

PMID:
16221068
19.

Staphylococcal vaccines: a realistic dream.

Fattom AI, Naso R.

Ann Med. 1996 Feb;28(1):43-6. Review.

PMID:
8932505
20.

Immunization with Staphylococcus aureus clumping factor B, a major determinant in nasal carriage, reduces nasal colonization in a murine model.

Schaffer AC, Solinga RM, Cocchiaro J, Portoles M, Kiser KB, Risley A, Randall SM, Valtulina V, Speziale P, Walsh E, Foster T, Lee JC.

Infect Immun. 2006 Apr;74(4):2145-53.

Supplemental Content

Support Center